1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

NEA Management Company, LLC Buys Sprout Social Inc, Trillium Therapeutics Inc, Genocea Biosciences Inc, Sells Dermira Inc, AVEO Pharmaceuticals Inc, Marker Therapeutics Inc

Timonium, MD, based Investment company NEA Management Company, LLC (Current Portfolio) buys Sprout Social Inc, Trillium Therapeutics Inc, Genocea Biosciences Inc, Marker Therapeutics Inc, AVEO Pharmaceuticals Inc, sells Dermira Inc, AVEO Pharmaceuticals Inc, Marker Therapeutics Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, NEA Management Company, LLC. As of 2020Q1, NEA Management Company, LLC owns 43 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

For the details of NEA Management Company, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/nea+management+company%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of NEA Management Company, LLC
  1. Ra Pharmaceuticals Inc (RARX) - 6,138,797 shares, 20.83% of the total portfolio.
  2. Sprout Social Inc (SPT) - 9,046,080 shares, 10.21% of the total portfolio. New Position
  3. Allakos Inc (ALLK) - 2,268,188 shares, 7.13% of the total portfolio.
  4. Cloudflare Inc (NET) - 4,059,376 shares, 6.74% of the total portfolio.
  5. Ardelyx Inc (ARDX) - 16,135,047 shares, 6.48% of the total portfolio.
New Purchase: Sprout Social Inc (SPT)

NEA Management Company, LLC initiated holding in Sprout Social Inc. The purchase prices were between $13 and $21.72, with an estimated average price of $18.25. The stock is now traded at around $18.01. The impact to a portfolio due to this purchase was 10.21%. The holding were 9,046,080 shares as of .

New Purchase: Genocea Biosciences Inc (GNCA)

NEA Management Company, LLC initiated holding in Genocea Biosciences Inc. The purchase prices were between $1.26 and $2.73, with an estimated average price of $2.03. The stock is now traded at around $2.24. The impact to a portfolio due to this purchase was 0.88%. The holding were 7,225,676 shares as of .

New Purchase: Marker Therapeutics Inc (MRKR)

NEA Management Company, LLC initiated holding in Marker Therapeutics Inc. The purchase prices were between $1.59 and $3.35, with an estimated average price of $2.57. The stock is now traded at around $2.32. The impact to a portfolio due to this purchase was 0.67%. The holding were 5,000,000 shares as of .

New Purchase: AVEO Pharmaceuticals Inc (VPA1)

NEA Management Company, LLC initiated holding in AVEO Pharmaceuticals Inc. The purchase prices were between $2.36 and $6.05, with an estimated average price of $4.51. The stock is now traded at around $7.45. The impact to a portfolio due to this purchase was 0.65%. The holding were 2,524,387 shares as of .

New Purchase: Lumos Pharma Inc (4NX1)

NEA Management Company, LLC initiated holding in Lumos Pharma Inc. The purchase prices were between $6.65 and $21.96, with an estimated average price of $12.74. The stock is now traded at around $8.50. The impact to a portfolio due to this purchase was 0.32%. The holding were 526,663 shares as of .

New Purchase: Endologix Inc (ELGX)

NEA Management Company, LLC initiated holding in Endologix Inc. The purchase prices were between $0.66 and $2.04, with an estimated average price of $1.24. The stock is now traded at around $0.89. The impact to a portfolio due to this purchase was 0.01%. The holding were 249,022 shares as of .

Added: Trillium Therapeutics Inc (TRIL)

NEA Management Company, LLC added to a holding in Trillium Therapeutics Inc by 173.16%. The purchase prices were between $1.03 and $7.22, with an estimated average price of $3.72. The stock is now traded at around $5.35. The impact to a portfolio due to this purchase was 1.04%. The holding were 5,736,363 shares as of .

Added: CTI BioPharma Corp (CTIC)

NEA Management Company, LLC added to a holding in CTI BioPharma Corp by 90.41%. The purchase prices were between $0.69 and $1.58, with an estimated average price of $1.16. The stock is now traded at around $1.01. The impact to a portfolio due to this purchase was 0.22%. The holding were 7,140,450 shares as of .

Sold Out: Dermira Inc (DERM)

NEA Management Company, LLC sold out a holding in Dermira Inc. The sale prices were between $14.65 and $19.19, with an estimated average price of $18.32.

Sold Out: AVEO Pharmaceuticals Inc (AVEO)

NEA Management Company, LLC sold out a holding in AVEO Pharmaceuticals Inc. The sale prices were between $2.6 and $6.86, with an estimated average price of $5.01.

Sold Out: Marker Therapeutics Inc (GX1N)

NEA Management Company, LLC sold out a holding in Marker Therapeutics Inc. The sale prices were between $1.48 and $2.93, with an estimated average price of $2.32.



Here is the complete portfolio of NEA Management Company, LLC. Also check out:

1. NEA Management Company, LLC's Undervalued Stocks
2. NEA Management Company, LLC's Top Growth Companies, and
3. NEA Management Company, LLC's High Yield stocks
4. Stocks that NEA Management Company, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)